BACKGROUND: Studies in persons without HIV infection have compared adipose tissue measured by dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI), but no such study has been conducted in HIV-infected (HIV+) subjects, who have a high prevalence of regional fat loss. OBJECTIVE: We compared DXA- with MRI-measured trunk, leg, arm, and total fat in HIV+ and control subjects. DESIGN: A cross-sectional analysis was conducted in 877 HIV+ subjects and 260 control subjects in FRAM (Study of Fat Redistribution and Metabolic Change in HIV Infection), stratified by sex and HIV status. RESULTS: Univariate associations of DXA with MRI were strongest for total and trunk fat (r > or = 0.92) and slightly weaker for leg (r > or = 0.87) and arm (r > or = 0.71) fat. The average estimated limb fat was substantially greater for DXA than for MRI for HIV+ and control men and women (all P < 0.0001). Less of a difference was observed in trunk fat measured by DXA and MRI, but the difference was still statistically significant (P < 0.0001). Bland-Altman plots showed increasing differences and variability. Greater average limb fat in control and HIV+ subjects (both P < 0.0001) was associated with greater differences between DXA and MRI measurements. Because the control subjects had more limb fat than did the HIV+ subjects, greater amounts of fat were measured by DXA than by MRI when control subjects were compared with HIV+ subjects. More HIV+ subjects had leg fat in the bottom decile of the control subjects by DXA than by MRI (P < 0.0001). CONCLUSIONS: Although DXA- and MRI-measured adipose tissue depots correlate strongly in HIV+ and control subjects, differences increase as average fat increases, particularly for limb fat. DXA may estimate a higher prevalence of peripheral lipoatrophy than does MRI in HIV+ subjects.
BACKGROUND: Studies in persons without HIV infection have compared adipose tissue measured by dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI), but no such study has been conducted in HIV-infected (HIV+) subjects, who have a high prevalence of regional fat loss. OBJECTIVE: We compared DXA- with MRI-measured trunk, leg, arm, and total fat in HIV+ and control subjects. DESIGN: A cross-sectional analysis was conducted in 877 HIV+ subjects and 260 control subjects in FRAM (Study of Fat Redistribution and Metabolic Change in HIV Infection), stratified by sex and HIV status. RESULTS: Univariate associations of DXA with MRI were strongest for total and trunk fat (r > or = 0.92) and slightly weaker for leg (r > or = 0.87) and arm (r > or = 0.71) fat. The average estimated limb fat was substantially greater for DXA than for MRI for HIV+ and control men and women (all P < 0.0001). Less of a difference was observed in trunk fat measured by DXA and MRI, but the difference was still statistically significant (P < 0.0001). Bland-Altman plots showed increasing differences and variability. Greater average limb fat in control and HIV+ subjects (both P < 0.0001) was associated with greater differences between DXA and MRI measurements. Because the control subjects had more limb fat than did the HIV+ subjects, greater amounts of fat were measured by DXA than by MRI when control subjects were compared with HIV+ subjects. More HIV+ subjects had leg fat in the bottom decile of the control subjects by DXA than by MRI (P < 0.0001). CONCLUSIONS: Although DXA- and MRI-measured adipose tissue depots correlate strongly in HIV+ and control subjects, differences increase as average fat increases, particularly for limb fat. DXA may estimate a higher prevalence of peripheral lipoatrophy than does MRI in HIV+ subjects.
Authors: Peter Bacchetti; Barbara Gripshover; Carl Grunfeld; Steven Heymsfield; Heather McCreath; Dennis Osmond; Michael Saag; Rebecca Scherzer; Michael Shlipak; Phyllis Tien Journal: J Acquir Immune Defic Syndr Date: 2005-10-01 Impact factor: 3.731
Authors: W Shen; M Punyanitya; J Chen; D Gallagher; J Albu; X Pi-Sunyer; C E Lewis; C Grunfeld; S B Heymsfield; S Heshka Journal: Int J Obes (Lond) Date: 2006-10-24 Impact factor: 5.095
Authors: Phyllis C Tien; Constance Benson; Andrew R Zolopa; Stephen Sidney; Dennis Osmond; Carl Grunfeld Journal: Am J Epidemiol Date: 2006-03-08 Impact factor: 4.897
Authors: G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage Journal: J Clin Epidemiol Date: 1988 Impact factor: 6.437
Authors: Carl Grunfeld; Michael Saag; Joseph Cofrancesco; Cora Elizabeth Lewis; Richard Kronmal; Steven Heymsfield; Phyllis C Tien; Peter Bacchetti; Michael Shlipak; Rebecca Scherzer Journal: AIDS Date: 2010-07-17 Impact factor: 4.177
Authors: Jacqueline Bauer; John Thornton; Steven Heymsfield; Kim Kelly; Alexander Ramirez; Sonia Gidwani; Dympna Gallagher Journal: Pediatr Res Date: 2012-07-20 Impact factor: 3.756
Authors: Todd T Brown; Shruti H Mehta; Catherine Sutcliffe; Yvonne Higgins; Michael S Torbenson; Richard D Moore; David L Thomas; Mark S Sulkowski Journal: AIDS Date: 2010-03-27 Impact factor: 4.177
Authors: Karin C Wu; Sisi Cao; Connie M Weaver; Nicole J King; Sheena Patel; Hillary Kingman; Deborah E Sellmeyer; Kathryn McCauley; Danny Li; Susan V Lynch; Tiffany Y Kim; Dennis M Black; Martin M Shafer; Mustafa Özçam; Din L Lin; Stanley J Rogers; Lygia Stewart; Jonathan T Carter; Andrew M Posselt; Anne L Schafer Journal: J Clin Endocrinol Metab Date: 2022-03-24 Impact factor: 5.958
Authors: Heidi J Silver; Kevin D Niswender; Joel Kullberg; Johan Berglund; Lars Johansson; Morten Bruvold; Malcolm J Avison; E Brian Welch Journal: Obesity (Silver Spring) Date: 2013-04 Impact factor: 5.002